# Evaluation of the "ST500 SINGLE- DOSE GEL" in Patients With Symptomatic Long Head of the Biceps Tendon Injury

> **NCT05785520** · NA · COMPLETED · sponsor: **Contrad Swiss SA** · enrollment: 35 (actual)

## Conditions studied

- Long Head of Biceps Rupture

## Interventions

- **DEVICE:** ST500 SINGLE-DOSE GEL

## Key facts

- **NCT ID:** NCT05785520
- **Lead sponsor:** Contrad Swiss SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-30
- **Primary completion:** 2022-10-10
- **Final completion:** 2022-10-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05785520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05785520, "Evaluation of the "ST500 SINGLE- DOSE GEL" in Patients With Symptomatic Long Head of the Biceps Tendon Injury". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05785520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*